The Asia Pacific Anastomosis Devices Market would witness Market growth of 7.2% CAGR during the forecast period (2022-2028).
Custom robotic deposition equipment was used to create easy-to-use silk-based resorbable as well as suture-less anastomosis devices. Retention strength, crush resistance, and leak resistance were all high in silk-based heparin-eluting devices. These devices were put to the test in a porcine implant, where they stayed intact. Histological research revealed that the implant wall was degrading and absorbing, indicating that cells were able to enter into the lamellar section of the device, indicating the possibility of tissue regeneration.
Anastomotic devices technology is rapidly advancing. The next generation of these devices, for both distal as well as proximal anastomoses, would be easier to load and deploy, and can enable anastomoses to be built in any order. The ability to instrument the graft solely through the piece that will be discarded, rather of the portion that will stay to act as a conduit, reduces the risk of endothelial injury, allowing more widespread usage of these devices with arterial conduits. With the advancement of these technologies, it can be able to perform multivessel CABG without cardiopulmonary bypass in less than half of the time and with much less morbidity.
The APAC Market is being majorly dominated by growing economies such as Japan, China, and India. Because of better economic conditions, rising healthcare awareness, and an ageing population in this region, the requirement for surgeries across this region is estimated to surge over the forecasting years. Because older people are more prone to gastrointestinal and cardiovascular problems, there would be an increase in the number of people requiring surgeries.
Obesity rates are rising at an alarming rate, particularly in urban areas. Between 1975 and 2016, the global prevalence of obesity nearly tripled. 30–65 percent of the adult urban population is overweight or obese. When compared to the rural population, the BMI of urban Indians is higher. The abdominal obesity, rather than the increased BMI, is a cause for concern. Men in urban areas have a waist-to-hip ratio of 0.99, whereas men in rural areas have a waist-to-hip ratio of 0.95. Obesity in the abdomen is also more common than obesity in general.
The China Market dominated the Asia Pacific Anastomosis Devices Market by Country 2021, and would continue to be a dominant Market till 2028; thereby, achieving a Market value of $411 million by 2028. The Japan Market is experiencing a CAGR of 6.6% during (2022 - 2028). Additionally, The India Market would exhibit a CAGR of 7.9% during (2022 - 2028).
Based on Product Type, the Market is segmented into Disposable and Reusable. Based on Application, the Market is segmented into Cardiovascular Surgery, Gastrointestinal Surgery and Others. Based on End User, the Market is segmented into Hospitals and Ambulatory Care Centers & Clinics. Based on countries, the Market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
Free Valuable Insights: The Worldwide Anastomosis Devices Market is Projected to reach USD 4.8 Billion by 2028, at a CAGR of 5.5%
The Market research report covers the analysis of key stake holders of the Market . Key companies profiled in the report include Medtronic PLC, LivaNova PLC, Becton, Dickinson and Company, Johnson & Johnson, Peters Surgical, Smith & Nephew PLC, Boston Scientific Corporation, B. Braun Melsungen AG, ConMed Corporation, and Baxter International, Inc.
By Product Type
By Application
By End User
By Country
Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
Unique Offerings 